Exhibit 99.1
Arbe Announces Third Quarter 2021 Results and Business Update
Strong Commercial Traction and Technology Leadership; Successfully Completed Business Combination in Early October
Tel Aviv, Israel, December 7, 2021- Arbe Robotics Ltd. (Nasdaq: ARBE) (“Arbe”), a global leader in next-generation 4D Imaging Radar Solutions, announced today third quarter 2021 financial results and provided a business update.
Kobi Marenko, Chief Executive Officer, said “We are excited to report a solid quarter of continued operational, technological, and strategic progress. Our successful business combination and presence on the NASDAQ market marks a significant milestone and helps to cement our leadership position ahead of what we see as an imminent, revolutionary change in the global automotive technology market. We look forward to demonstrating the value of our next-generation Imaging Radar and its importance to the future of the automotive industry. We are progressing and paving the road for the adoption of our technology and for the universal acceptance of our products.”
Karine Pinto-Flomenboim, Chief Financial Officer, added, “We remain confident in the full range of our projections for growth, our financial performance, the expansion of our operational capabilities, the pace of progress in our research and development efforts, and the adoption of our technology and products by a range of important customers around the world.”
Commercial Traction
| ● | A top global OEM selected Arbe for an “Imaging Radar - based perception” project |
| ● | Weifu announced it reached a road pilot phase of its Arbe-based Radar Systems and is scheduled to be in full production by the end of 2022 |
| ● | BAIC Group’s Deputy General Manager announced that Arbe’s technology will be installed on its mass-produced models |
| ● | Hyundai holds a PoC of safety enhancements introduced by Arbe’s next generation radars |
| ● | On schedule with a pre-production project with the Top 5 OEM, which is progressing towards selection in 2022 |
| ● | On track with the production plan for Auto-X |
Technology Leadership
| ● | Arbe was presented with the 2021 Europe New Product Innovation Award by Frost & Sullivan |
| ● | Arbe was named a CES 2022 Innovation Awards Honoree for its Phoenix Perception Radar |
| ● | Arbe’s 4D Imaging Radar Technology won ADAS & Autonomous Product of the Year 2021 by Informa Tech Automotive |
| ● | Arbe delivered radar samples based on our final production chipset with the highest physical resolution in the industry |
| ● | Arbe’s AI layer is receiving strong feedback following pilot trials from leading automotive companies |
Arbe’s Third Quarter 2021 Financial Highlights
| ● | Revenues for Q3 2021 were $0.6 million. The company continues to see strong interest for its products and expects this positive momentum to continue. Revenue for the first nine months of 2021, was $1.7 million |
| ● | Backlog as of September 30, 2021 was $2.0 million, consistent with expectations of demand to support prototyping, pilot programs and engineering support, with additional new orders expected in the fourth quarter |
| ● | Operating expenses for Q3 2021 were $8.5 million, an increase from $3.4 million in Q3 2020. The increase was primarily related to headcount growth and a return towards normal business conditions in 2021. The company continues strengthening its R&D investment, with R&D expenses totaling $7.4 million for Q3 2021, compared to $2.9 million of R&D expenses in Q3 2020 |
| ● | Q3 2021 Net loss of ($13.3) million, which included $5.0 million of financial expenses mostly related to the revaluations of convertible loan and warrants, compared with a net loss of ($3.3) million for Q3 of 2020 |
| ● | Adjusted EBITDA, a non-GAAP measurement which adds back depreciation and amortization, financial expenses and equity-based expenses, was ($8.0) million compared to ($3.3) million in the third quarter of 2020 |
| ● | As of September 30, 2021, before the Business Combination, Arbe had $4.0 million in cash and cash equivalents, compared to $2.9 million in cash and cash equivalents as of December 31, 2020 |
| ● | Total gross proceeds resulting from the Business Combination with ITAC, which was completed on October 7th, were approximately $118.3 million, out of which total transaction costs amounted to approximately $19.4 million |
| ● | Arbe’s post balance sheet events include $9.2 million received from the exercise of warrants issued to the ITAC warrant holder as part of the business combination |
Outlook
| ● | Arbe reaffirms its forward-looking guidance for 2025 of including revenue $312 million, representing identified projects with deep engagement |
| ● | Based on year-to-date backlog and expected new orders, the Company reiterates its expectation for 2021 booking |
Investor Event
Arbe will host an investor event (https://arberobotics.com/investorevent/) today at 10am Eastern Time, which will include commentary on its third quarter 2021 financial performance and Q&A. The presentation will be available on the Company's website following the event.
About Arbe
Arbe (Nasdaq: ARBE), a global leader in next-generation 4D Imaging Radar Chipset Solutions, is spearheading a radar revolution, enabling truly safe driver-assist systems today while paving the way to full autonomous-driving. Arbe’s imaging radar is 100 times more detailed than any other radar on the market and is a mandatory sensor for L2+ and higher autonomy. The company is empowering automakers, tier-1 suppliers, autonomous ground vehicles, commercial and industrial vehicles, and a wide array of safety applications with advanced sensing and paradigm-changing perception. Arbe is a leader in the fast-growing automotive radar market that has an estimated projected total addressable market of $11 billion in 2025. Arbe is based in Tel Aviv, Israel, and has an office in the United States.
Use of Non-GAAP Financial Measures
This press release contains financial information calculated other than in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). The non-GAAP measures presented by the Company are not measures of financial performance in accordance with GAAP and may exclude items that are significant in understanding and assessing the Company’s financial results. Therefore, these measures should not be considered in isolation or as an alternative to net income, cash flows from operations or other measures of profitability, liquidity or performance under GAAP. Arbe’s presentation of these measures may not be comparable to similarly-titled measures used by other companies. These non-GAAP financial measures are subject to inherent limitations as they reflect the exercise of judgments by management about which expense and income are excluded or included in determining these non-GAAP financial measures and should be considered in addition to, and not as a substitute for, comparable GAAP measures. The non-GAAP measures used in this press release are Non-GAAP Net Loss and Adjusted EBITDA. The Company provides these non-GAAP financial measures because it believes that they present a measure of the Company’s core business that management uses internally to evaluate the Company’s ongoing performance. Reconciliations of these non-GAAP measures to the Company’s Net Loss can be found immediately following the Consolidated Statements of Cash Flows included in this press release. In evaluating Arbe, undue reliance should not be placed on the non-GAAP financial information.
2
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding Arbe’s current beliefs, plans and expectations, including, without limitation, Arbe’s belief that it will continue to be able to execute strongly on its business plan. Words such as “believe,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “goal,” “could,” “would,” “should,” “if,” “may,” “might,” “future,” “target,” “trend,” “seek to,” “will continue,” “predict,” “likely,” “in the event,” “potential” and variations of any such words or similar expressions are indicate forward-looking statements.
Forward-looking statements are made on the basis of management’s current views and assumptions and are not guarantees of future performance. Forward-looking statements are inherently subject to risks and uncertainties that could cause actual results, and actual events that occur, to differ materially from results contemplated by the forward-looking statements. These risks and uncertainties include, but are not limited to: (i) unanticipated delays or difficulties in connection with the evaluation of Arbe’s products in evaluation and test programs; (ii) the success of road pilot programs for Arbe’s products, (iii) Arbe’s ability to develop significant revenue as a result of the test programs involving its radar system; (iv) Arbe’s ability to leverage its existing relationships and secure test programs and orders resulting from the test programs; (v) Arbe’s ability to meet its projected revenue level and its ability to operate profitably; (vi) Arbe’s expectation that it will be engaging with Tier 1 suppliers and OEMs which would be building the radars based on its Chipset solution, eliminating expenses associated with system completion, requirement for undertaking significant capital expenditures associated with developing mass production manufacturing and the expenses of operating any such manufacturing capability; (vii) Arbe’s expectation that radars are crucial to the automotive industry and will be deployed in nearly all new vehicles as a long range, cost-effective sensor with the fewest environmental limitations; (viii) Arbe’s belief that the Arbe Radar Chipset heralds a breakthrough in radar technology that will enable Tier 1 manufacturers and OEMs to replace the current radars with an advanced solution that meets the safety requirements of Euro-NCAP and NHTSA for autonomous vehicles at all levels of autonomous driving; (ix) Arbe’s ability to develop or have access to the latest developments relating to radar and autonomous driving vehicles; (x) Arbe’s ability to have products manufactured for it by third parties that meet Arbe’s and its customers quality standards and delivery requirements; (xi) Arbe’s ability to attract and retain highly skilled personnel and senior management, including research and development, sales and marketing personnel; (xii) Arbe’s ability to obtain funding when required through debt and equity financings; (xiii) the effect of inflation and supply chain problems on Arbe’s business, including Arbe’s ability to obtain semiconductor products when needed and at a reasonable price; (xiv) Arbe’s ability to develop and market products based on its radar technology for uses outside of the automotive industry; (xv) accidents or bad press resulting from accidents involving autonomous driving vehicles, even those using radar products from other companies or based on other technology;and the effect of any accidents with vehicles using Arbe’s radar system; (xvi) the failure of the markets for Arbe’s current or new technologies and products to materialize to the extent or at the rate that Arbe expects; (xvii) unexpected delays or difficulties related to the development of Arbe’s technologies and products; (xviii) the effect of laws and changes in laws that have an effect on the market for or the requirement for autonomous vehicles; (xix) the effect of COVID-19 and any new variants or any pandemics or multinational epidemics and actions taken by governments and industry to address the effects of the pandemic and the corresponding macroeconomic uncertainty; (xvii) risks related to the potential impact of new accounting standards on Arbe’s financial position, results of operations or cash flows; (xx) changes or inaccuracies in market projections; (xxi) changes in Arbe’s business strategy; and (xxii) the risk and uncertainties described in “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Cautionary Note Regarding Forward-Looking Statements’’ and the additional risks described in Arbe’s prospectus dated November 2, 2021 which which was filed filed by Arbe with the Securities and Exchange Commission on November 4, 2021, as well as the other documents filed by Arbe with the SEC. Arbe undertakes no duty to revise or update publicly any forward-looking statement for any reason, except as otherwise required by law.
Contact
DeeDee Rudenstein
Propel Strategic Communications
267-521-9654
drudenstein@propelsc.com
Nathan Elwell
Lincoln Churchill Advisors
847-530-0249
nelwell@lincolnchurchilladvisors.com
Shlomit Hacohen, CMO
Arbe Robotics Ltd.
+972-54-5422432
shlomit.h@arberobotics.com
3
CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands)
September 30, 2021 | December 31, 2020 | |||||||
| Current Assets: | (Unaudited) | (Audited) | ||||||
| Cash and cash equivalents | 3,929 | 2,857 | ||||||
| Restricted cash | 120 | 97 | ||||||
| Short term bank deposits | - | 100 | ||||||
| Trade Receivable | 365 | 137 | ||||||
| Prepaid expenses and other receivables | 904 | 830 | ||||||
| Total current assets | 5,318 | 4,021 | ||||||
| Non-Current Asset | ||||||||
| Deferred transaction costs * | 1,685 | - | ||||||
| Property and equipment, net | 826 | 384 | ||||||
| Total non-current assets | 2,511 | 384 | ||||||
| Total assets | 7,829 | 4,405 | ||||||
| Current liabilities: | ||||||||
| Current maturities of long-term loan | - | 1,879 | ||||||
| Short term loan | 4,780 | - | ||||||
| Trade payables | 2,854 | 1,209 | ||||||
| Employees and payroll accruals | 2,503 | 1,538 | ||||||
| Deferred revenues | 1,012 | 281 | ||||||
| Accrued expenses and other payables | 2,264 | 364 | ||||||
| Total current liabilities | 13,413 | 5,271 | ||||||
| Long term liabilities | ||||||||
| Long-term loan | - | 676 | ||||||
| Convertible loan | 30,844 | 1,641 | ||||||
| Warrants to purchase Series B-1 preferred shares | 1,751 | 375 | ||||||
| Warrants to purchase Series B-2 preferred shares | 1,906 | 1,159 | ||||||
| Total long-term liabilities | 34,501 | 3,851 | ||||||
| REDEEMABLE CONVERTIBLE PREFERRED SHARES | 61,560 | 55,440 | ||||||
| SHAREHOLDERS’ DEFICIENCY: | ||||||||
| Ordinary Shares | *) | *) | ||||||
| Additional paid-in capital | 2,154 | 1,397 | ||||||
| Accumulated Deficit | (103,799 | ) | (61,554 | ) | ||||
| Total shareholders’ deficiency | (101,645 | ) | (60,157 | ) | ||||
| Total liabilities, redeemable convertible preferred shares and shareholders’ deficiency | 7,829 | 4,405 | ||||||
| * | Represents transaction costs incurred by Arbe in consummating the transaction. $1.7 million were recorded against accrued expenses. |
4
CONSOLIDATED STATEMENTS OF OPERATIONS
(U.S. dollars in thousands, except share and per share data)
| 3 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | |||||||||||||
September 30, 2021 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
| Revenues | 628 | - | 1,729 | 138 | ||||||||||||
| Cost of revenues | 438 | 90 | 1,116 | 227 | ||||||||||||
| Gross Profit (Loss) | 190 | (90 | ) | 613 | (89 | ) | ||||||||||
| Operating Expenses: | ||||||||||||||||
| Research and development, net | 7,432 | 2,890 | 16,984 | 9,515 | ||||||||||||
| Sales and marketing | 390 | 192 | 1,137 | 752 | ||||||||||||
| General and administrative | 674 | 285 | 1,793 | 792 | ||||||||||||
| Total operating expenses | 8,496 | 3,367 | 19,914 | 11,059 | ||||||||||||
| Operating loss | (8,306 | ) | (3,457 | ) | (19,301 | ) | (11,148 | ) | ||||||||
| Financial expenses (income), net | 4,980 | (126 | ) | 22,944 | (27 | ) | ||||||||||
| Net loss | (13,286 | ) | (3,331 | ) | (42,245 | ) | (11,121 | ) | ||||||||
| Basic and diluted net loss per share attributable to Ordinary Shareholders | (1.35 | ) | (0.36 | ) | (4.40 | ) | (1.21 | ) | ||||||||
| Weighted-average number of shares used in computing basic and diluted net loss per share attributable to Ordinary Shareholders* | 9,870,463 | 9,238,425 | 9,596,666 | 9,182,514 | ||||||||||||
| * | The number of ordinary shares retroactively reflects the 46.25783-for-one stock split of the ordinary shares which was effective on October 7, 2021. |
5
CONSOLIDATED STATEMENTS OF CASH FLOWS
(U.S. dollars in thousands)
| 9 Months Ended | 9 Months Ended | |||||||
September 30, 2021 | September 30, 2020 | |||||||
| Cash flows from operating activities: | (Unaudited) | (Unaudited) | ||||||
| Net Loss | (42,245 | ) | (11,121 | ) | ||||
| Adjustments to reconcile loss to net cash used in operating activities: | ||||||||
| Depreciation | 246 | 255 | ||||||
| Stock-based compensation | 488 | 290 | ||||||
| Warrants to service providers | 56 | 43 | ||||||
| Revaluation of warrants and accretion | 4,738 | 268 | ||||||
| Revaluation of convertible loan | 17,866 | - | ||||||
| Change in operating assets and liabilities: | ||||||||
| Decrease (increase) in trade receivable | (162 | ) | 28 | |||||
| Decrease (increase) in prepaid expenses and other receivables | (74 | ) | (33 | ) | ||||
| Increase (decrease) in trade payables | 1,645 | (1,400 | ) | |||||
| Increase in employees and payroll accruals | 965 | (525 | ) | |||||
| Increase in deferred revenue | 665 | 124 | ||||||
| Increase in accrued expenses and other payables | 331 | 200 | ||||||
| Net cash used in operating activities | (15,481 | ) | (11,871 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Change in bank deposits | 100 | 7,860 | ||||||
| Purchase of property and equipment | (687 | ) | (156 | ) | ||||
| Net cash provided by (used in) investing activities | (587 | ) | 7,704 | |||||
| Cash flows from financing activities: | ||||||||
| Repayment of long-term loan | (2,639 | ) | (1,161 | ) | ||||
| Proceeds from short term loan | 4,733 | |||||||
| Payment of deferred transaction costs | (117 | ) | ||||||
| Proceeds from issuance of redeemable convertible preferred shares and warrants for the purchase of Series B-2 redeemable convertible preferred shares, net | - | 1,190 | ||||||
| Proceeds from exercise of warrants | 3,637 | |||||||
| Proceeds from exercise of options | 212 | 30 | ||||||
| Proceeds from convertible loan | 11,337 | |||||||
| Net cash provided by financing activities | 17,163 | 59 | ||||||
| Increase (decrease) in cash, cash equivalents and restricted cash | 1,095 | (4,108 | ) | |||||
| Cash, cash equivalents and restricted cash at the beginning of the year | 2,954 | 7,003 | ||||||
| Cash, cash equivalents and restricted cash at the end of the period | 4,049 | 2,895 | ||||||
6
RECONCILIATION OF GAAP NET LOSS TO NON-GAAP NET LOSS
(U.S. dollars in thousands, except share and per share data)
| 3 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | |||||||||||||
September 30, 2021 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
| GAAP net loss attributable to ordinary shareholders | (13,286 | ) | (3,331 | ) | (42,245 | ) | (11,121 | ) | ||||||||
| Add: | ||||||||||||||||
| Stock-based compensation | 176 | 83 | 488 | 290 | ||||||||||||
| Warrants to service providers | 19 | 15 | 56 | 43 | ||||||||||||
| Revaluation of warrants and accretion | 612 | 114 | 4,738 | 268 | ||||||||||||
| Revaluation of convertible loan | 4,160 | - | 17,866 | - | ||||||||||||
| Non-GAAP net loss | (8,319 | ) | (3,119 | ) | (19,097 | ) | (10,520 | ) | ||||||||
| Basic and diluted Non-GAAP net loss per share attributable to Ordinary Shareholders | (0.84 | ) | (0.34 | ) | (1.99 | ) | (1.15 | ) | ||||||||
| Weighted-average number of shares used in computing basic and diluted Non-GAAP net loss per share attributable to Ordinary Shareholders* | 9,870,463 | 9,238,425 | 9,596,666 | 9,182,514 | ||||||||||||
| * | The number of ordinary shares retroactively reflects the 46.25783-for-one stock split of the ordinary shares which was effective on October 7, 2021. |
RECONCILIATION OF GAAP NET LOSS TO AJUSTED EBITDA
(U.S. dollars in thousands)
| 3 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | |||||||||||||
September 30, 2021 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
| GAAP net loss attributable to ordinary shareholders | (13,286 | ) | (3,331 | ) | (42,245 | ) | (11,121 | ) | ||||||||
| Add: | ||||||||||||||||
| Financial expenses (income), net | 4,980 | (126 | ) | 22,944 | (27 | ) | ||||||||||
| Depreciation & Amortization | 97 | 41 | 246 | 255 | ||||||||||||
| Stock-based compensation | 176 | 83 | 488 | 290 | ||||||||||||
| Warrants to service providers | 19 | 15 | 56 | 43 | ||||||||||||
| Adjusted EBITDA | (8,014 | ) | (3,318 | ) | (18,511 | ) | (10,560 | ) | ||||||||
7